Global Janus Kinase (JAK) Inhibitors Market
JAK Inhibitors Market Surges as Autoimmune Diseases Demand Cutting-Edge Solutions, 2032F: Revenues for Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, and Other Inhibitor Types
November 01, 2023 08:18 ET | Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Janus Kinase (JAK) Inhibitors Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global Janus Kinase (JAK)...
22157.jpg
Acute Myeloid Leukemia (AML) Therapeutics Market Set to Reach $3.7 Billion by 2032: New Pipeline Agents Drive Growth
October 31, 2023 08:58 ET | Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been added to ...
Global Aspirin Market
Technological Advancements and Increasing Prevalence of Arthritis Drive Innovation in the Global Aspirin Market
October 24, 2023 04:08 ET | Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Aspirin Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global aspirin market is expected to experience...
Global Tofacitinib Market
Global Tofacitinib Market Research Report 2023
October 17, 2023 05:18 ET | Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Tofacitinib Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global tofacitinib market is expected to grow...
22157.jpg
United States Bispecific Antibodies Market & Clinical Pipeline Research Report 2023: Potential Market Opportunity of $15 Billion By 2028 - Dosage, Price and Sales Insights
October 16, 2023 07:03 ET | Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "US Bispecific Antibodies Market & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The US...
22157.jpg
Addressing Unmet Needs: The SLE Market Grows as Research and Development Flourish
October 06, 2023 06:08 ET | Research and Markets
Dublin, Oct. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with...
22157.jpg
Lupus Nephritis Drug Pipeline Research Report 2023: Comprehensive Insights about 20+ Companies and 25+ Pipeline Drugs
October 04, 2023 10:23 ET | Research and Markets
Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The "Lupus Nephritis - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Lupus Nephritis - Pipeline...
Global HIV Drugs Market
Global HIV Drugs Market Research Report 2023-2031: Antiretroviral Therapy (ART) Emerging as Pivotal Tool in Managing HIV and Enhancing Well-Being
October 03, 2023 06:58 ET | Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global HIV Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global HIV drugs market value...
Global Sulfasalazine Market
Emerging Markets Offer Growth Opportunities: Sulfasalazine Manufacturers Target Untapped Potential
October 03, 2023 06:13 ET | Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Sulfasalazine Market, By Product Type, By Application, By Distribution Channel, By Patient Demographics, By Disease Severity, By Prescription Type, By...
Global Lymphedema Treatment Market
Global Lymphedema Treatment Market: Promising Growth Ahead with Projected Valuation of $1.74 Billion by 2030
September 25, 2023 05:03 ET | Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Global Lymphedema Treatment Market Size, Share, Growth Analysis, By End-User, By Product, By Condition Type, By Treatment Type - Industry Forecast...